{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:47:16Z","timestamp":1776397636459,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijrobp.2014.12.052","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T08:12:00Z","timestamp":1426839120000},"page":"1017-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Volumetric Modulated Arc Therapy Planning for\u00a0Primary Prostate Cancer With Selective Intraprostatic Boost Determined by 18F-Choline PET\/CT"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8557-7340","authenticated-orcid":false,"given":"Yu","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-0532","authenticated-orcid":false,"given":"Kyle","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-5198","authenticated-orcid":false,"given":"Miles","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandi A.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.12.052_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijrobp.2007.09.020","article-title":"Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer","volume":"71","author":"Kupelian","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.eururo.2011.08.029","article-title":"Dose escalation for prostate cancer radiotherapy: Predictors of long-term biochemical tumor control and distant metastases-free survival outcomes","volume":"60","author":"Zelefsky","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","article-title":"Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials","volume":"74","author":"Viani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijrobp.2012.05.023","article-title":"Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"85","author":"Spratt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","article-title":"Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning","volume":"53","author":"Cellini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1259\/bjr.75.890.750151","article-title":"Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy","volume":"75","author":"Nutting","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2013.04.027","article-title":"Boosting imaging defined dominant prostatic tumors: A systematic review","volume":"107","author":"Bauman","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-014-1557-y","article-title":"Re-evaluating the concept of \u201cdominant\/index tumor nodule\u201d in multifocal prostate cancer","volume":"464","author":"Huang","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.10039.x","article-title":"Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: Active surveillance and focal targeted therapy","volume":"108","author":"Mouraviev","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00259-004-1755-y","article-title":"Prostate cancer: A comparative study of 11c-choline PET and MR imaging combined with proton MR spectroscopy","volume":"32","author":"Yamaguchi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.semnuclmed.2007.07.003","article-title":"Cancer imaging with fluorine-18-labeled choline derivatives","volume":"37","author":"Kwee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib14","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2967\/jnumed.109.063396","article-title":"Detection of aggressive primary prostate cancer with 11c-choline PET\/CT using multimodality fusion techniques","volume":"50","author":"Piert","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2310\/7290.2008.00002","article-title":"Use of step-section histopathology to evaluate 18f-fluorocholine PET sextant localization of prostate cancer","volume":"7","author":"Kwee","year":"2008","journal-title":"Mol Imaging"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib16","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1016\/j.ijrobp.2012.01.087","article-title":"Intensity modulated radiation therapy dose painting for localized prostate cancer using 11C-choline positron emission tomography scans","volume":"83","author":"Chang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00066-010-2122-5","article-title":"Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost","volume":"186","author":"Pinkawa","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1748-717X-7-14","article-title":"Dose-escalation using intensity-modulated radiotherapy for prostate cancer\u2014evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost","volume":"7","author":"Pinkawa","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijrobp.2011.09.015","article-title":"A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment","volume":"83","author":"Quan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ijrobp.2010.04.025","article-title":"Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: A planning comparison study","volume":"79","author":"Ost","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"NCCN clinical practice guidelines in oncology: Prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib22","unstructured":"Michalski J, Purdy J, Bruner D, et\u00a0al. A phase III randomized study of high dose 3DCRT\/IMRT versus standard dose 3DCRT\/IMRT in patients treated for localized prostate cancer. RTOG 0126 Protocol Information.\u00a0Available at: http:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0126."},{"key":"10.1016\/j.ijrobp.2014.12.052_bib23","first-page":"262","article-title":"Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET","volume":"47","author":"Kwee","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2011.03.012","article-title":"Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy","volume":"99","author":"Chang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijrobp.2014.01.042","article-title":"Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions","volume":"89","author":"Murray","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1259\/bjr\/20476567","article-title":"Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using biosuite","volume":"85","author":"Uzan","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib27","first-page":"13","article-title":"Tumour control probability modelling: Basic principles and applications in treatment planning","volume":"17","author":"Nahum","year":"2001","journal-title":"Physica Medica"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib28","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res Suppl"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib31","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2009.07.014","article-title":"Dose-escalation using intensity-modulated radiotherapy for prostate cancer\u2013evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost","volume":"93","author":"Pinkawa","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2014.05.050","article-title":"(18)F-choline positron emission tomography\/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: Feasibility study in 60 patients","volume":"90","author":"D'Angelillo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib35","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib36","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","article-title":"Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer","volume":"117","author":"Alicikus","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.radonc.2009.08.010","article-title":"Carbon-11 acetate PET\/CT based dose escalated IMRT in prostate cancer","volume":"93","author":"Seppala","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib38","doi-asserted-by":"crossref","first-page":"20130813","DOI":"10.1259\/bjr.20130813","article-title":"Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters","volume":"87","author":"Riches","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.juro.2012.06.010","article-title":"Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy","volume":"188","author":"Nguyen","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1748-717X-7-82","article-title":"Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: Implications for focal therapy","volume":"7","author":"Vainshtein","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2009.07.1689","article-title":"Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: A sequential dose escalation pilot study","volume":"78","author":"Miralbell","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib42","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00259-014-2793-8","article-title":"PET\/CT imaging and the oligometastatic prostate cancer patient: An opportunity for a curative approach with high-dose radiotherapy?","volume":"41","author":"Miralbell","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib43","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/pros.21347","article-title":"High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer","volume":"71","author":"Schick","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiol.2352040494","article-title":"Fluorocholine PET\/CT in patients with prostate cancer: Initial experience","volume":"235","author":"Schmid","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/pcan.2011.35","article-title":"18F-fluorocholine for prostate cancer imaging: A systematic review of the literature","volume":"15","author":"Bauman","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ijrobp.2014.12.052_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1464-410X.2009.08347.x","article-title":"Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?","volume":"104","author":"Tareen","year":"2009","journal-title":"BJU Int"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614045660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614045660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T01:41:41Z","timestamp":1598838101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614045660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0360301614045660"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.052","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volumetric Modulated Arc Therapy Planning for\u00a0Primary Prostate Cancer With Selective Intraprostatic Boost Determined by 18F-Choline PET\/CT","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.12.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}